4.5 Review

The role of histone methylation in renal cell cancer: an update

Journal

MOLECULAR BIOLOGY REPORTS
Volume 50, Issue 3, Pages 2735-2742

Publisher

SPRINGER
DOI: 10.1007/s11033-022-08124-3

Keywords

Histone methylation; Renal cell cancer; Lysine methyltransferases; Ezh2; Dot1l

Ask authors/readers for more resources

Renal cell carcinoma, accounting for 2-3% of all cancers, is challenging to diagnose early. Recent genome-wide studies have found that histone methylation is commonly dysregulated in renal cell cancer. Mutations or dysregulation of histone methylation, methyltransferases, and demethylases are associated with gene expression and tumor progression in renal cell cancer.
Renal cell carcinoma accounts for 2-3% of all cancers. It is difficult to diagnose early. Recently, genome-wide studies have identified that histone methylation was one of the functional classes that is most frequently dysregulated in renal cell cancer. Mutation or mis-regulation of histone methylation, methyltransferases, demethylases are associated with gene expression and tumor progression in renal cell cancer. Herein, we summarize histone methylations, demethylases and their alterations and mechanisms in renal cell cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available